Stock Detail
Videos
PolyPid (PYPD) Company Webcast
PolyPid Ltd. (NASDAQ: PYPD) is a late-stage biopharmaceutical company developing innovative therapies designed to improve surgical outcomes and reduce post-operative complications. The company's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology enables...
PolyPid (PYPD) Company Webcast
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
PolyPid (PYPD) Fireside Chat
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. This fireside chat was recorded during the Lytham Partners Fall 2025 Investor Conference.
News
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX
PolyPid Submitted Marketing Authorization Application to European Medicines Agency for D-PLEX Last month Validation confirms that the application is complete and EMA initiates formal review of D-PLEX D-PLEX NDA concurrently under FDA Priority Review with November 28,...
PolyPid Regains European Commercialization Rights for D-PLEX , Expanding Global Commercialization Opportunities
PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today...
PolyPid Announces Participation in Upcoming Fall Investor Conferences
PETACH TIKVA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today...